Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine: Dexmedetomidine (50 g) will be used as an adjuvant to 0.5% bupivacaine (18 ml) in ultrasound-guided supraclavicular brachial plexus block. The drug will be administere
Sponsors
Mahatma Gandhi Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patient posted for upper limb surgery patients of all genders Patient aged between 18-65 years patient with American society of anaesthesiologists (ASA) class I and II
Exclusion criteria
Exclusion criteria: Patient with history of drug allergy patient with newly diagnosed coagulopathy infection at the injection site Pre-existing neurological deficits in the operative limb Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset time of sensory and motor block following ultrasound-guided supraclavicular brachial plexus block.Timepoint: Sensory and motor block will be assessed every 2 minutes after administration of the block until complete block is achieved. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of sensory & motor block after ultrasound-guided supraclavicular brachial plexus block.Timepoint: From the time of complete sensory & motor block until full recovery of sensory & motor function, assessed postoperatively up to 24 hours. | — |
Countries
India
Contacts
Public ContactDr Munesh Meena
Mahatma Gandhi Medical College and Hospital
Outcome results
None listed